ARCHIVES

ASCO Ends Early Distribution Of Abstracts To Halt “ASCO Effect” On Stock Market

This article is from The Cancer Letter archive.

Vol. 29 No. 04 | January 24, 2003

Download PDF Visit The Full Archive

Related Articles

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

March 20, 2009

Recalcitrant Cancer Bill Heading To Senate May Face Hold in the Lame Duck Session

November 16, 2012

Gleevec Approval Sets Record For FDA Review: 73 Days

May 25, 2001

Kathy Giusti Named One of The TIME’s 100 Most Influential People

April 22, 2011

FCRF Program Proving Good Basic Research Can Be Supported By NCI With a Contract

January 23, 1987

Biomedical Panel Says Cancer Panel Should Expand to Serve all NIH

June 4, 1976